UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	August 3, 2017

Accession Number:	0001144204-17-039309
Submission Type:	POS AM
CIK: 0001425205 Company Name: IOVANCE BIOTHERAPEUTICS, INC. File Number: 333-214073